Streamline your approval processes and tackle increasing costs! Overcome the challenges of shrinking government budgets, anticipate market demand and improve your product’s value proposition.
Featuring world-class case studies and hours of industry leader interaction, you will take away comprehensive advice and practical solutions to seize market access opportunities in Canada’s rapidly changing pharmaceutical landscape.
Gather actionable tips to:
This is North America’s biggest Market Access event! Register now for the 15th Annual Market Access Summit, Toronto 2016.
Imran Ali is the Senior Manager of the pan-Canadian Pharmaceutical Alliance Office and has been in the role since September 2015. From 2012 to 2015, Imran held the position of Senior Manager with the Agreements & Negotiations Unit in the Ontario Ministry of Health and Long-Term Care’s Negotiations Branch. In this role, Imran provided leadership and direction for planning, priority setting and negotiation of accountability agreements with individual providers and health care organizations to optimize the Ministry’s investment in the health care system valued at over $11 billion annually. Imran provided support for the negotiations process with the Ontario Medical Association (OMA). Prior to this, Imran supported the negotiations of the 2012 Physician Services Agreement with the OMA and lead the coordination of subsequent implementation activities related to the agreement. He also served as the Ministry Co-Chair for the Systems Management Committee, which is responsible for bilateral monitoring and analysis of physician services in Ontario with the OMA. Imran began his career with the Ministry in 2006 with the Primary Health Care Branch where he managed physician services contracts valued in excess of $50 million annually in the Specialized Models Unit. Imran graduated with a Masters in Public Health specializing in Health Policy and Management from the University of Alberta's School of Public Health in 2005.
A career public servant, Doug has a background in international trade law, intellectual property policy, pharmaceutical industry issues and competition law enforcement.
Doug attended McGill University, the University of New Brunswick and l'Université de Moncton. He graduated law school in 1997 and was called to the Ontario Bar in 1999 after a clerkship with the Honourable Marc Noël of the Federal Court of Appeal.
In 2000, Doug was hired by Industry Canada to assist in the case management of two WTO-based legal challenges to Canada’s pharmaceutical patent regime brought by the US and EU. In 2006, Doug became the Director of the Patent and Trademark Policy Directorate at Industry Canada, where he led a number of legislative and regulatory initiatives under the Patent Act and Trademarks Act, including the development of Canada’s Access to Medicines Regime (CAMR) and pharmaceutical patent litigation reform. In 2009, Doug joined the Competition Bureau as Assistant Deputy Commissioner, Civil Matters Branch, where he was responsible for a number of high profile prosecutions under the Competition Act.
Doug became Executive Director of the PMPRB on October 28, 2013.
As a doctor trained at the Université de Sherbrooke and a specialist in public health, he holds a master’s in health administration from the Université de Montréal and a fellowship from the Canadian Health Services Research Foundation. In addition to his clinical experience—particularly in emergency medicine—over the last 25 years, he has acquired solid experience in the management of health institutions and public health organizations, as well as the regional and national governance of health systems, while participating in and managing several projects. At the international level, he has also implemented and directed many study projects and missions, particularly in Africa. Between 1993 and 2001, Dr. Boileau assumed the ministerial mandate of Director of Public Health, and between 2001 and 2008, the role of President and Director General of the Agence de la santé et des services sociaux de la Montérégie, a region of 1.5 million people located southwest of Montréal. In October 2008, the Government of Quebec appointed him as President and Director General of the Institut national de santé publique du Québec, a central organisation gathering the public health expertise required by the health and social services network in the province. Ambassador of the Université de Sherbrooke for which he acts as an associate professor, as well as the Université de Montréal, he is an active member on board of directors of prestigious organizations such as the Canadian Institute for Health Information, the Canadian Foundation for Healthcare Improvement, the Quebec Network for Personalized Health Care and the Institut de Recherches Cliniques de Montréal.
Steve Hill is Director, Market Access & Government Affairs, PTC Therapeutics Canada. Steve has worked in the pharmaceutical/biotech industry for 25 years and directly in market access for half of that time. Steve contributed to the successful launch in Canada of 20 new products and new product indications. In this Case Study session, Steve will share some things he has learned from experience navigating the gap between the regulatory process and reimbursement landscape in Canada.